Esophageal Cancer Clinical Trials in Vienna
2 recruitingVienna, Austria
Showing 1–2 of 2 trials
Recruiting
Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Esophageal CancerGastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca2,130 enrolled230 locationsNCT07431281
Recruiting
Not Applicable
PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer
Oesophageal CancerRectal Cancer Stage
Johannes Laengle, MD, PhD20 enrolled1 locationNCT04564482